NewsCoinbase CEO Brian Armstrong Bags $130M for Longevity Startup NewLimit
Andrea7 May 20255 min read
While most crypto CEOs are busy navigating market volatility, Brian Armstrong Brian Armstrong at coinbase Brian Armstrong is the Co-Founder and CEO of Coinbase, the largest digital asset exchange in the United States. Since 2012, Armstrong has played a major role in pushing cryptocurrency toward mainstream use. His work focuses on building a strong connection between traditional financial systems and the growing Web3 ecosystem. Under his leadership, Coinbase achieved a major milestone in 2021 when it became the first large crypto exchange to go public on the Nasdaq. The event was a key milestone for the crypto industry. It contributed to increased institutional confidence in digital assets and revealed that larger financial players are beginning to take the sector more seriously. Over the last few years, Brian Armstrong has dedicated his efforts to fortifying blockchain infrastructure. At the same time, he has been promoting the need for clearer regulatory frameworks to support the long-term expansion of the crypto market. Quick Facts Full name Brian Armstrong Birth January 25, 1983 Education Rice University (B.A. in Economics and Computer Science; M.S. in Computer Science) Nationality American Martial Status Married Net Worth Estimated between $9 billion and $14 billion Career Overview Brian Armstrong began his career as a software engineer at Airbnb. During his time there, he regularly faced the difficulties of international payments. Sending money across countries was often slow, complicated, and filled with delays. During 2025 and early 2026, Brian Armstrong spent more time strengthening on-chain infrastructure while also pushing for clearer regulations for the crypto industry. He supported the expansion of Base, Coinbase’s Layer-2 network. The network later started integrating private transaction capabilities after Coinbase acquired the Iron Fish team. Brian Armstrong: Timeline of events 2012: Co-founded Coinbase after participating in the Y Combinator startup program. 2015: Launched Coinbase Exchange, built specifically for professional traders. 2017: Led Coinbase during the massive crypto bull run, when the app became one of the most downloaded apps on the App Store. 2021: Took Coinbase public through a historic Direct Listing (IPO) on the Nasdaq, reaching a peak valuation of more than $100 billion. 2022: Guided Coinbase through the challenging Crypto Winter and launched the Coinbase NFT marketplace. 2023: Introduced Base, a Layer-2 Ethereum scaling solution designed to grow the on-chain economy. 2024: Helped secure approval for the iShares Bitcoin Trust (IBIT), with Coinbase acting as the main custodian for BlackRock. 2025: Acquired the team behind Iron Fish to bring privacy features into the Base network. 2026: Spoke at major crypto forums and held discussions with the Trump administration about the federal stablecoin regulatory framework. Recognition of Brian Armstrong: Year Recognition Details 2012 Y Combinator Alumnus Selected for the prestigious accelerator to build Coinbase. 2017 Fortune 40 Under 40 Recognized for pioneering the retail crypto exchange model. 2021 Nasdaq Direct Listing Orchestrated the first public listing of a major US crypto exchange. 2023 Base Mainnet Launch Released Coinbase's proprietary L2 network for decentralized apps. 2025 Iron Fish Team Acquisition Strategic move to bring on-chain privacy to the Coinbase ecosystem. EntrepreneurInvestorDeveloper/ProgrammerCrypto and Blockchain Expert is playing a far bigger game – taking on human aging and Washington regulations at the same time. Not exactly your typical founder story, right?
One moment he’s rallying for stablecoin legislation on Capitol Hill, the next he’s funding research to literally reverse the aging process.
Here’s the latest on Armstrong, for all Coinbase enthusiasts out there!
NewLimit Raises $130M to Rewire Human Longevity
Armstrong’s biotech venture NewLimit, co-founded with former GV partner Blake Byers and stem cell scientist Jacob Kimmel, just closed a $130 million Series B round. The startup, now valued at $810 million, is developing therapies that aim to restore youthful function to aging cells through epigenetic reprogramming.
Early results are promising. The team has identified three prototype medicines targeting liver cells – improving their fat and alcohol processing capabilities in lab tests.
While human trials are still years away, NewLimit is expanding into immune system research, with Armstrong citing the urgency of fighting what he calls the “largest source of human tragedy” – aging.
The round was led by Kleiner Perkins and backed by a powerful lineup of investors including Founders Fund, Elad Gil, Patrick Collison, and Garry Tan.
Say No to Aging: Tech Titans Are All In!
Armstrong isn’t alone in this mission. He joins the ranks of tech elites like Jeff Bezos, Larry Ellison, and Vitalik Buterin – all pouring hundreds of millions into anti-aging research. But Armstrong’s approach is distinctive: part-scientist, part-operator, and always ten steps ahead.
Fighting for Stablecoin Regulations
The Coinbase CEO hasn’t loosened his grip on crypto advocacy. Just yesterday on X, he called on the U.S. Senate to move forward on the GENIUS Act – a stablecoin regulation bill that could finally bring clear rules to the space.
The GENIUS Act would introduce a federal licensing regime, enforce reserve requirements for issuers, and create a dual regulatory model – splitting oversight between federal and state levels depending on issuer size.
The push comes just as the Treasury predicts stablecoins could surge from $230B to $2T by 2028, presenting both an opportunity and a risk to traditional banking systems.
Never Miss a Beat in the Crypto World!
Stay ahead with breaking news, expert analysis, and real-time updates on the latest trends in Bitcoin, altcoins, DeFi, NFTs, and more.
Here’s how we see it: Brian Armstrong is betting on the future, and he’s doing it from all sides.
FAQs
- NewLimit is a biotech startup co-founded by Brian Armstrong to reverse aging via epigenetic cell reprogramming.
